PRSS + TAU for Opioid Use Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if adding peer recovery support services (PRSS) helps individuals adhere to their medication for opioid use disorder (MOUD) more effectively than usual treatment alone. PRSS provides support from individuals with personal experience in substance use, offering coaching and guidance. The trial will compare two groups: one receiving usual care and another receiving usual care plus PRSS. Ideal candidates for this trial live in recovery residences, are already taking MOUD, and are not currently receiving formal peer support. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance recovery support strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it requires participants to be on medications for opioid use disorder (MOUD) like methadone, buprenorphine, or naltrexone.
What prior data suggests that Peer Recovery Support Services (PRSS) are safe for individuals with opioid use disorder?
Research shows that Peer Recovery Support Services (PRSS) can be a safe and helpful option for people with opioid use disorder. Studies have found that those who receive peer support often find it beneficial for their recovery. For instance, one study found that PRSS can help more people start and continue using medications for opioid use disorder (MOUD).
The evidence suggests that PRSS is generally well-received. People in various settings have reported positive experiences with peer support, often feeling understood and supported by someone who has faced similar challenges. While some gaps remain in the research, the available data does not show any serious safety concerns related to PRSS.
Overall, PRSS is seen as a promising way to help improve treatment retention and outcomes for those dealing with opioid addiction.12345Why are researchers excited about this trial?
Researchers are excited about Peer Recovery Support Services (PRSS) + Treatment as Usual (TAU) for opioid use disorder because it introduces a unique support system that differs from traditional medication or therapy-based treatments. Unlike standard treatments that primarily focus on medication-assisted therapy like methadone or buprenorphine, PRSS leverages peer support to enhance recovery. This method aims to improve retention in medication programs by building community and offering lived-experience insights, which can provide a more relatable and motivational recovery journey. By integrating peer support with usual care, this approach could lead to better long-term recovery outcomes and increased adherence to medication plans.
What evidence suggests that this trial's treatments could be effective for opioid use disorder?
Research has shown that Peer Recovery Support Services (PRSS) can assist individuals with substance use problems, such as opioid use disorder (OUD). Some studies have found that PRSS, which involves support from those who have faced similar challenges, helps individuals remain engaged in treatment. Early findings suggest that PRSS might encourage adherence to medications for opioid use disorder (MOUD), which is crucial for reducing the risk of relapse and overdose. However, more research is needed to confirm PRSS's effectiveness in supporting MOUD adherence. In this trial, one group will receive PRSS combined with Treatment as Usual (TAU), while another group will receive TAU alone. Combining PRSS with regular treatment aims to leverage both structured support and shared personal experiences to improve outcomes for those with OUD.12367
Who Is on the Research Team?
Marc Fishman, MD
Principal Investigator
Mountain Manor Treatment Center - Maryland Treatment Centers
Kevin R. Wenzel, Ph.D.
Principal Investigator
Mountain Manor Treatment Center - Maryland Treatment Centers
Are You a Good Fit for This Trial?
This trial is for adults over 18 with Opioid Use Disorder (OUD) who live in a Recovery Residence (RR) and are on Medications for Opioid Use Disorder (MOUD). They must speak English, be able to consent, and not already receiving formal Peer Recovery Support Services outside of the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Preparation
Preparation for the intervention including building a network of recovery residences, recruiting and training peer support specialists, conducting focus groups and interviews, and developing PRSS approaches to promote MOUD retention.
Intervention
Pilot test the PRSS intervention by randomizing 50 individuals on MOUD to either a 24-week course of the PRSS intervention added to usual services, or usual services without the PRSS intervention.
Post-Intervention
Gather additional input from former participants and RR staff post-intervention to further refine the intervention and inform trial design and data collection procedures for the next-step R01 application.
Follow-up
Participants are monitored for MOUD retention and other outcomes at weeks 36 and 52.
What Are the Treatments Tested in This Trial?
Interventions
- Peer Recovery Support Services (PRSS) + TAU
- Treatment as Usual (TAU)
Peer Recovery Support Services (PRSS) + TAU is already approved in United States for the following indications:
- Substance Use Disorder (SUD) support
- Medications for Opioid Use Disorder (MOUD) retention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Potomac Health Foundations
Lead Sponsor
National Institute of Drug Abuse
Collaborator
National Institutes of Health (NIH)
Collaborator